Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
A2 Biotherapeutics Inc.
Azienda Ospedaliero-Universitaria di Parma
A2 Biotherapeutics Inc.
Verismo Therapeutics
CRISPR Therapeutics
M.D. Anderson Cancer Center
Nurix Therapeutics, Inc.
TCR2 Therapeutics
TCR2 Therapeutics
Context Therapeutics Inc.
Numab Therapeutics AG
NuCana plc
Telix Pharmaceuticals (Innovations) Pty Limited
Medicenna Therapeutics, Inc.
Ascentage Pharma Group Inc.
Cancer Research UK
Novartis
University of Pennsylvania